Cargando…
Targeting Oncoimmune Drivers of Cancer Metastasis
SIMPLE SUMMARY: Despite great advances in the detailed profiling of tumor cells and the development of therapeutic agents, cancer metastasis is still a big hurdle in the treatment of cancer patients. This is possibly because tumor cells plastically evolve through interplay with the host environment,...
Autores principales: | Kudo-Saito, Chie, Ozaki, Yukinori, Imazeki, Hiroshi, Hayashi, Hideyuki, Masuda, Jun, Ozawa, Hiroki, Ogiwara, Yamato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867187/ https://www.ncbi.nlm.nih.gov/pubmed/33535613 http://dx.doi.org/10.3390/cancers13030554 |
Ejemplares similares
-
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer
por: Ozawa, Hiroki, et al.
Publicado: (2021) -
CD11b(+)CTLA4(+) myeloid cells are a key driver of tumor evasion in colorectal cancer
por: Imazeki, Hiroshi, et al.
Publicado: (2021) -
The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response
por: Rose, Mélanie, et al.
Publicado: (2021) -
The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity
por: Zhang, Geng, et al.
Publicado: (2020) -
Oncolytic viruses are a recent breakthrough in oncoimmune treatment: recent insights – correspondence
por: Amin, Ruhul, et al.
Publicado: (2023)